======= NAT8 ======= == Gene Information == * **Official Symbol**: N/AT8 * **Official Name**: N-acetyltransferase 8 (putative) * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9027|9027]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UHE5|Q9UHE5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NAT8&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NAT8|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606716|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acetylates the free alpha-amino group of cysteine S- conjugates to form mercapturic acids (PubMed:20392701). This is the final step in a major route for detoxification of a wide variety of reactive electrophiles which starts with their incorporation into glutathione S-conjugates. The glutathione S- conjugates are then further processed into cysteine S-conjugates and finally mercapturic acids which are water soluble and can be readily excreted in urine or bile. Alternatively, may have a lysine N-acetyltransferase activity catalyzing peptidyl-lysine N6- acetylation of various proteins. Thereby, may regulate apoptosis through the acetylation and the regulation of the expression of PROM1 (PubMed:24556617). May also regulate amyloid beta-peptide secretion through acetylation of BACE1 and the regulation of its expression in neurons (PubMed:19011241). {ECO:0000269|PubMed:19011241, ECO:0000269|PubMed:20392701, ECO:0000269|PubMed:24556617}. |Acetyltransf 1| |cysteine-S-conjugate N-acetyltransferase activity| |peptidyl-lysine N6-acetylation| |lysine N-acetyltransferase activity, acting on acetyl phosphate as donor| |amyloid-beta metabolic process| |glutathione metabolic process| |endoplasmic reticulum-Golgi intermediate compartment membrane| |endoplasmic reticulum-Golgi intermediate compartment| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |protein acetylation| |protein acylation| |cellular modified amino acid metabolic process| |peptidyl-lysine modification| |sulfur compound metabolic process| |cofactor metabolic process| |peptide metabolic process| |cellular amide metabolic process| |peptidyl-amino acid modification| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |endoplasmic reticulum membrane| |negative regulation of cell death| |endoplasmic reticulum| |response to drug| |regulation of apoptotic process| |regulation of programmed cell death| |regulation of cell death| |positive regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp54|Taxol 0.002μM R01 exp54]]|1.77| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8761 * **Expression level (log2 read counts)**: -5.6 {{:chemogenomics:nalm6 dist.png?nolink |}}